Mosaic ImmunoEngineering, Inc. (CPMV)
OTCMKTS · Delayed Price · Currency is USD
0.3330
+0.2705 (432.80%)
At close: Oct 9, 2026
Mosaic ImmunoEngineering Market Cap
Mosaic ImmunoEngineering has a market cap or net worth of $2.41 million as of October 20, 2026. It is the 47,478th most valuable company in the world and the 6,362nd biggest in the United States. Its market cap has decreased by 26.00% in one year.
Market Cap
2.41M
Enterprise Value
4.11M
Revenue
n/a
Global Rank
Country Rank
#6,362 United States
PE Ratio
n/a
ChartMarket Cap Chart
Since October 15, 2020, Mosaic ImmunoEngineering's market cap has increased from 1.69M to 2.41M, an increase of 43.05%. That is a compound annual growth rate of 6.16%.
| Date | Market Cap | % Change |
|---|---|---|
| Oct 9, 2026 | 2.41M | 7.07% |
| Dec 31, 2025 | 2.25M | -55.65% |
| Dec 31, 2024 | 5.08M | 16.87% |
| Dec 29, 2023 | 4.35M | -39.39% |
| Dec 30, 2022 | 7.17M | -2.75% |
| Dec 31, 2021 | 7.37M | 181.52% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Oct 15, 2020 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Affymax | 3.10M |
| Vaccinex | 2.68M |
| Bioxytran | 2.57M |
| GPL Holdings | 2.56M |
| Pacific Software | 2.50M |
| Enzolytics | 2.42M |
| Abpro Holdings | 2.41M |
| AccuStem Sciences | 2.37M |